| Dr Nancy Elizabeth Bolan, RN, FNP, CNM, PHD | |
|
655 W Lombard St, Baltimore, MD 21201-1512 | |
| (202) 699-2511 | |
| Not Available |
| Full Name | Dr Nancy Elizabeth Bolan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 655 W Lombard St, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033708425 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | 428602 (New York) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | F331022 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Elizabeth Bolan, RN, FNP, CNM, PHD 50 Parkway W, Mount Vernon, NY 10552-1141 Ph: (202) 699-2511 | Dr Nancy Elizabeth Bolan, RN, FNP, CNM, PHD 655 W Lombard St, Baltimore, MD 21201-1512 Ph: (202) 699-2511 |
News Archive
Cytta Corp is pleased to announce that we have now successfully completed the first client installation and deployment of our remote medical monitoring system. This installation enables the Company to commence a full scale roll out of its technology, concentrating initially on our clients consisting of payors and providers, such as: Health Plans, Managed Care Organizations, Health Delivery Organizations, Medical Groups and IPAs, located in the Southern California area.
A major route toward creating effective vaccines against dengue virus and Zika involves the E protein that covers the surface of each viral particle.
Vertex Pharmaceuticals Incorporated today announced interim results from an ongoing Phase 2 study designed to assess the safety and tolerability of 12-week response-guided treatment regimens with its polymerase inhibitor, VX-222, and its protease inhibitor, telaprevir, in combination with pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment.
For many inherited diseases, such as cystic fibrosis or Huntington disease, the disease-causing genetic mutation damages or removes a protein that has an essential role in the body. This protein defect is the root cause of the disease symptoms.
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
› Verified 2 days ago
Ms. Lindsay Bream O'meara, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Suite S4d07, Baltimore, MD 21201 Phone: 410-328-3365 | |
Mrs. Tamara Jeanne Setola, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7001 Johnnycake Rd Ste 101, Baltimore, MD 21244 Phone: 410-719-0063 | |
Christina Fang, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1838 Greene Tree Rd, Suite 400, Baltimore, MD 21208 Phone: 410-602-7782 Fax: 410-602-2438 | |
Alison C Eissler, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 312 N. Martin Luther King Jr. Blvd, Suite 102, Baltimore, MD 21201 Phone: 610-716-0192 | |
Mrs. Rebecca Delaney Tsao, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 98 North Broadway, Suite 421, Baltimore, MD 21231 Phone: 410-955-6211 | |
Andrew Brave, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-9000 | |
Maria Marcela Montenegro, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16 S Eutaw St Fl 1, Baltimore, MD 21201 Phone: 410-328-5408 Fax: 410-328-1909 |